We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.


Item № 18093
CAS № 1022150-57-7
Purity ≥98%
product image
                (CAS 1022150-57-7)
     1 mg $35.00 0.00
     5 mg $131.00 0.00
     10 mg $228.00 0.00
     25 mg $438.00 0.00

Pricing updated 2019-07-18. Prices are subject to change without notice.


The hepatocyte growth factor receptor c-Met commonly shows elevated activity in several forms of cancer.1,2 SGX523 is a potent, selective, ATP-competitive inhibitor that blocks the tyrosine kinase activity of c-Met with an IC50 value of 4 nM.1 It is over 1,000-fold selective for c-Met over a panel of other kinases.1 SGX523 is orally active and dose-dependently inhibits the growth of a variety of tumor xenografts in mice.1,3 The effectiveness of SGX523 is enhanced when combined with other chemotherapeutic compounds, including inhibitors of EGFR.2,4 SGX523 is metabolized, at least in part, by aldehyde oxidase, an enzyme that differs in activity across different species.5

Recommended Products

Related Products
View Related Product Categories
Technical Information
Formal Name
CAS Number
Molecular Formula
Formula Weight
A crystalline solid
212, 234 nm
InChI Code
InChI Key

Warning - this product is not for human or veterinary use.

Shipping & Storage
Room temperature in continental US; may vary elsewhere
≥ 2 years
Downloads & Resources
Product Downloads

Download Product Insert

Download Safety Data Sheet (SDS)

Download free InChI Key generation software

Additional Information

View the Cayman Structure Database for chemical structure definitions for many Cayman products

Get Batch-Specific Data and Documents by Batch Number

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.

References & Product Citations
Product Description References

1. Buchanan, S.G., Hendle, J., Lee, P.S., et al. SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo Molecular Cancer Therapeutics 8(12), 3181-3190 (2009).

2. Padda, S., Neal, J.W., and Wakelee, H.A. MET inhibitors in combination with other therapies in non-small cell lung cancer Transl.Lung Cancer Res. 1(4), 238-253 (2012).

3. Guessous, F., Zhang, Y., diPierro, C., et al. An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth Anticancer Agents Med.Chem. 10(1), 28-35 (2010).

4. Zhang, Y.W., Staal, B., Essenburg, C., et al. Strengthening context-dependent anticancer effects on non-small cell lung carcinoma by inhibition of both MET and EGFR Molecular Cancer Therapeutics 12(8), 1429-1441 (2013).

5. Diamond, S., Boer, J., Maduskuie, T.P., Jr., et al. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications Drug Metabolism and Disposition 38(8), 1277-1285 (2010).

Technical Support
Contact Us
  • Toll Free Phone (USA and Canada Only): (888) 526-5351
  • Direct Phone: (734) 975-3888
Cayman Contract Services

We work with scientists to accelerate their research, drug discovery, and drug development needs through our expertise in the following areas:

Cayman Chemical

1180 East Ellsworth Road

Ann Arbor, Michigan 48108 USA

Toll Free: (800) 364-9897

(USA and Canada Only)

Fax: (734) 971-3640